 |
|
Wednesday, May 07, 2008 |
 |
|
|
|
 |
|
|
MAJOR Live & Webcast LAB Auction
Thursday, May 15th, 11AM (ET)
Featuring Equipment from Millennium &
a Recently Operating Biotech LAB and More!
Bid Live On Location: 50 Hudson Road, Canton, MA
or Bid via the Web!
Featuring:
Micromass Quattro Ultima Mass Spec, HP 1100 HPLC Systems, Finnigan-MAT LCQ Mass Spec, Rigaku RU-H3R X-Ray, Labconco Freeze Dryers, Micromass Platform LCZ Mass Spec, B Braun Biostat-B, Shimadzu GC 17A, Buchi RotoVaps, Microscopes, Centrifuges, Water Baths, Microscopes, Revco -80s and Much Much, More!
Auction: Thursday, May 15th, 11AM (ET)
Bid Live On-Site in Canton, MA or Bid via Webcast!
Complete Info: http://www.equipnet.com/
EquipNet Auctions
 Going Strong: Genzyme Corporation
First quarter was a roller coaster ride for the market, driven by hope and fear. While just about every category of stocks has been hammered in recent months, biotech has edged up the past several weeks. Investors have been betting that the biotech business model, which relies on breakthrough technologies and long-term contracts, can weather the economic storm in the U.S.
On April 21, 2008, Genzyme/NASDAQ: GENZ said it will have to reapply with the FDA for the approval of Myozyme. Myozyme produced at the 160 liter bioreactor scale and Myozyme produced at the 2000 liter scale should be classified as two different products because of differences in the carbohydrate structures of the molecules. Currently, Myozyme is manufactured at the 160 liter bioreactor scale and treats Pompe disease, a genetic disorder that impairs muscle function and can be life-threatening if the disease affects the lungs or heart. The drug is approved in more than 40 nations, but not yet in the U.S. The FDA has agreed to give priority review to the new application using data from a prior study with the 2,000 liter process. That means the FDA will make a decision on the drug within six months.
The delay prompted the company to cut its Myozyme guidance for 2008 to between $275 million and $285 million from between $320 million and $330 million. Profit will now reach about $2.65 per share, compared with prior guidance of $2.75 per share. Genzyme anticipates that Myozyme will be available commercially in the U.S. in the first quarter of 2009. Myozyme is an important component of Genzyme's growth story, with estimated peak sales of about $1 billion.
Eventually, Myozyme will be approved, hence, we maintain Genzyme's target price of $79.
More Wong's Biotech Stock Report |
|
|
|
|
Latest Market Insight
Drug Approval Trends at the FDA and EMEA
Process improvements, heightened scrutiny and industry response
• Delayed approvals. Regulators are requesting more data to validate or refute conclusions about product risks. This is creating a rise in the size and number of clinical trials as well as overall research budgets.
• Rising R&D costs. Drug developers are continually increasing their R&D expenditures to generate approvable drug applications, despite rising financial pressures in the industry. Emerging technologies such as stem cells, genomics and proteomics are among the most prevalent initiatives being used to identify appropriate drug candidates.
• US generics focus. The FDA is allocating resources to generic drug approvals in an attempt to speed these products to market. However, although Europe has recently developed a clear regulatory path for generic versions of biologicals, this is yet be achieved in the US.
• Regulatory process improvements. Regulators are enhancing their drug review processes with new technologies such as electronic drug applications and technology-based standards for drug review.
Click Here for More Information |
|
|
|
|
|
|
|
Neurogen Corporation Facilities
35 Northeast Industrial Road
Branford, Connecticut 06405
U.S.A.
• Building Size: 58,061 sq. ft. (gross area)
• Land Area: 3.29 acres
• Parking: 150 spaces
More Real Estate Listings
|
Hot Company
Purdue Pharmaceuticals L.P.
4701 Purdue Drive
Wilson, North Carolina 27893 U.S.A.
Phone: 252-265-1900 Fax: 252-243-2533
View Jobs
Purdue Pharmaceuticals L.P. is a 240,000 square foot, state-of-the-art pharmaceutical manufacturing and packaging plant that produces tablets and capsules in bottle and blister trade pack configurations for Purdue Pharma L.P., an independent associated company headquartered in Stamford, CT. These privately held companies, founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care, are dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The companies have long been known for their pioneering research on persistent pain, a principal cause of human suffering.
More Company Profiles
|
DIA Annual Convention:
Join more than 8,000 attendees as they share information about the latest innovations in drug development and search for solutions to industry challenges.
Highlights of this year's event:
• Over 360 sessions across 26 content areas
• 40 preconference tutorials
• Over 1000 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
• 500+ exhibiting companies
• Networking Reception at the Boston Museum of Science
Please click here for more information.
More Investor Events
More Business Development Events |
• Biotech Beach (Orange County, California) Hot Job of the Day:
Integrium
Director of Business Development - West Coast
The Business Development Director is responsible for securing new business from pharmaceutical, biotech, and device companies within Integrium’s target market in the assigned territory.
• Bio NC (Morrisville, North Carolina) Hot Job of the Day:
Schering-Plough Corporation
Director, Commercial Development
Manage the customers and sales process from initial contact through the signing of a contract by using all tools at their disposal including involving senior management, marketing and sales support.
• Pharm Country (Upper Gwynedd, Pennsylvania) Hot Job of the Day:
Smith Hanley Consulting Group
Medical Program Financial Specialist II
Support the financial management of IISP by developing and maintaining a direct working relationship with the Global Research Specialists, Company Financial Specialist Administrator, paralegals, finance departments, Company subsidiary offices and external customers.
• Genetown (Cambridge, Massachusetts) Hot Job of the Day:
Biogen Idec
Sr Analyst III, Business Analysis
Seeking a Senior Oracle Applications Business Systems Analyst (Sr. Analyst III, Business Analyst) experienced in the Oracle 11i finance modules. A qualified candidate must have specific functional experience in Oracle G/L, A/R, A/P, F/A, and Tax. Practical experience with the one or more of these areas is a plus: Project Accounting, Process Manufacturing, and Cost Accounting.
• Biotech Bay (Palo Alto, California) Hot Job of the Day:
CV Therapeutics, Inc.
Analyst/Senior Financial Analyst
The Analyst/Sr. Financial Analyst will develop appropriate budgets and forecasts and will assist in monitoring and analyzing actual financial performance to those financial forecasts. The Analyst/Sr. Financial Analyst will work to identify emerging financial issues in Research and Operations.
Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center! |
BioSpace.com is pleased to present the Boehringer Ingelheim Career Fair on Thursday, May 8th at The Sheraton Boston Hotel in Boston, Massachusetts from 11:00 a.m. to 4:00 p.m. You must pre-register in order to attend this event.
For this event, Boehringer Ingelheim is ONLY interviewing candidates with the following backgrounds:
• Immunology/Inflammatory Disease Research - Scientists with BS, MS, and/or PhD
• Medicinal Chemistry - Scientists and Principal Scientists with MS or PhD
• Cardiovascular Disease Research - Scientists and Principal Scientists with MS or PhD
• Translational Sciences - Director level with PhD experience in Systems Biology and/or Electronic Biology
• Biologics/Biomolecular Sciences - Scientists and Principal Scientists with BS, MS, or Ph.D. and experience in Antibody/protein engineering
• Animal Resources - Facility Managers with BS and GLP experience
• Clinical Trial Support - Scientists with BS or MS degree in related field
We look forward to seeing you at the Boehringer Ingelheim Career Fair!
• Boehringer Ingelheim Career Fair, May 8, 2008
• Pharm Country Career Fair, June 5, 2008
• DDT - BioSpace 2008 Career Fair, August 6, 2008
• DeviceSpace Career Fair, September 8, 2008
• BioCapital Career Fair, September 30, 2008
• Biotech Bay Career Fair, October 14, 2008
More information about BioSpace's Career Fairs |
If someone forwarded this news to you and you'd like to
receive your own copy FREE of charge, simply join the BioSpace Deals & Dollars here.
Safely unsubscribe from Biospace.com e-mail at any time by managing your account here or by clicking
on the "unsubscribe" link at the bottom of this
newsletter. |
Send questions and comments to the
BioSpace NewsBeat Team
East Coast Office:
BioSpace, Inc.
Ramshorn Executive Centre
2399 Highway 34, Building A-5
Manasquan, New Jersey 08736-1528 U.S.A.
Phone: 732-528-3688
Fax: 732-528-3668
West Coast Office:
BioSpace, Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217
Editor & Publisher:
Editorial & Production Staff:
Annalyn Aquino
Suvarna Bhatt
Lana Ho
BioSpace.com - Where Life Sciences Thrive. |
• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing
the information published herein, we do not assume, and hereby disclaim, any liability
for any loss or damage caused by errors or omissions, whether such errors or omissions
resulted from negligence, accident or other causes.
|
|
 |
 |
|